Want to see SE:NEXAM full AI Analyst Report?
Top Page
Nexam Chemical Holding AB
(NEXAM)
Select Model
Select Model
Rating:43Neutral
Price Target:
kr2.50
▲(6.38% Upside)
Action:Reiterated
Date:10/17/26
The score is held down primarily by weak financial performance (TTM losses, negative gross/operating profit, and negative operating/free cash flow) and bearish technical signals (below key moving averages with very weak RSI/Stoch). A comparatively solid balance sheet with low leverage provides some support, but valuation is difficult to assess given the negative P/E and lack of dividend yield.
Positive Factors
Conservative balance sheet
Low leverage and declining debt provide financial resilience while reducing pressure from interest obligations. A sizable equity base gives Nexam greater capacity to absorb operating weakness and preserve strategic flexibility as it works to improve profitability.
Negative Factors
Declining and volatile revenue
Recent revenue contraction and volatility indicate that customer demand or commercial execution has not yet produced a dependable growth trend. Persistent top-line weakness can limit operating leverage, reduce investment capacity, and make recovery in earnings more difficult.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
Low leverage and declining debt provide financial resilience while reducing pressure from interest obligations. A sizable equity base gives Nexam greater capacity to absorb operating weakness and preserve strategic flexibility as it works to improve profitability.
Read all positive factors
Nexam Chemical Holding AB (NEXAM) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr251.11M
Dividend YieldN/A
Average Volume (3M)128.72K
Price to Earnings (P/E)―
Beta (1Y)0.18
Revenue Growth-4.57%
EPS Growth-15.20%
CountrySE
Employees60
SectorBasic Materials
Sector Strength58
IndustryChemicals
Share Statistics
EPS (TTM)-0.20
Shares Outstanding102,493,350
10 Day Avg. Volume141,000
30 Day Avg. Volume128,715
Financial Highlights & Ratios
PEG Ratio-0.15
Price to Book (P/B)1.18
Price to Sales (P/S)1.04
P/FCF Ratio27.58
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.06
Revenue Forecast (FY)kr210.00M
Nexam Chemical Holding AB Business Overview & Revenue Model
Company Description
Nexam Chemical Holding AB (publ) specializes in creating advanced chemical solutions designed to elevate the properties and performance of various polymers. Operating globally, with a strong presence in Sweden and Europe, the company delivers prod...
How the Company Makes Money
Nexam Chemical makes money primarily by selling chemical products/additives used in polymer and plastics manufacturing. Its core revenue stream is generated from commercial sales of these additives to industrial customers (e.g., plastics manufactu...
Nexam Chemical Holding AB Financial Statement Overview
Summary
Income Statement
28
Negative
Balance Sheet
66
Positive
Cash Flow
41
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 188.69M | 192.25M | 199.58M | 190.28M | 221.76M | 219.45M |
| Gross Profit | -68.76M | -11.81M | 92.40M | 81.79M | 86.73M | 84.48M |
| EBITDA | 1.91M | 4.12M | 10.52M | -5.01M | 780.00K | 6.30M |
| Net Income | -18.45M | -16.53M | -9.01M | -22.84M | -12.71M | -5.46M |
Balance Sheet | ||||||
| Total Assets | 251.07M | 225.95M | 231.13M | 245.81M | 278.10M | 284.35M |
| Cash, Cash Equivalents and Short-Term Investments | 16.74M | 12.17M | 2.88M | 9.06M | 22.88M | 63.60M |
| Total Debt | 15.96M | 28.22M | 23.10M | 26.15M | 31.84M | 27.72M |
| Total Liabilities | 47.61M | 57.78M | 47.82M | 52.75M | 62.48M | 56.28M |
| Stockholders Equity | 203.46M | 168.17M | 183.31M | 193.06M | 215.62M | 228.06M |
Cash Flow | ||||||
| Free Cash Flow | -2.45M | 7.22M | -2.47M | -9.53M | -44.22M | 516.00K |
| Operating Cash Flow | -14.18M | 11.29M | 7.43M | -352.00K | -11.10M | 7.19M |
| Investing Cash Flow | -16.01M | -9.57M | -9.71M | -9.18M | -33.12M | -6.25M |
| Financing Cash Flow | 35.65M | 1.44M | -3.06M | -5.17M | 3.85M | 33.23M |
Nexam Chemical Holding AB Technical Analysis
Negative
2.35
Price Trends
2.76
Negative
2.98
Negative
2.82
Negative
Market Momentum
-0.07
Negative
44.18
Neutral
52.46
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:NEXAM, the sentiment is Negative. The current price of 2.35 is below the 20-day moving average (MA) of 2.45, below the 50-day MA of 2.76, and below the 200-day MA of 2.82, indicating a neutral trend. The MACD of -0.07 indicates Negative momentum. The RSI at 44.18 is Neutral, neither overbought nor oversold. The STOCH value of 52.46 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:NEXAM.
Nexam Chemical Holding AB Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | kr800.39M | 10.96 | 10.54% | 4.19% | -13.36% | -31.32% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
48 Neutral | kr87.95M | -1.59 | -176.65% | ― | -21.95% | -28.77% | |
44 Neutral | kr80.72M | -18.52 | -1.52% | 7.50% | -18.26% | 35.77% | |
43 Neutral | kr251.11M | -12.01 | -9.37% | ― | -4.57% | -15.20% | |
43 Neutral | kr128.64M | -6.76 | -27.51% | ― | 36.35% | 38.34% | |
42 Neutral | kr23.72M | -0.54 | -87.92% | 0.00% | -11.55% | 60.56% |
* Basic Materials Sector Average
SE:NEXAM
Nexam Chemical Holding AB
2.45
-0.79
-24.38%
SE:AERO
Svenska Aerogel Holding AB
0.45
-0.96
-68.42%
SE:POLYG
Polygiene AB
2.21
-6.99
-75.98%
SE:AXIC.A
aXichem AB Class A
1.69
-0.85
-33.43%
SE:ORGC
OrganoClick AB
0.48
-1.30
-73.03%
SE:ARPL
Arla Plast AB
38.15
-19.81
-34.18%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.